Assignee
NETRIS PHARMA
FR·4 granted patents·4 pending applications·8 citations·filing 2013–2024
Top patents by PatentIndex Score
8 records- 0186US10494427B2Anti-netrin-1 antibodyNETRIS PHARMA·Filed 2015·Granted Dec 3, 2019·8 cites·14 claims
- 0260US11648309B2Anti-netrin-1 antibodyNETRIS PHARMA·Filed 2019·Granted May 16, 2023·0 cites·12 claims
- 0359US2025002572A1Combined treatment with netrin-1 interfering drug and immune checkpoint inhibitors drugsNETRIS PHARMA·Filed 2024·Application pending·0 cites
- 0451US2025215071A1Novel Mcl-1 inhibitor and combination of Mcl-1 and a BH3 mimetic, such as a Bcl-2 inhibitorNETRIS PHARMA·Filed 2023·Application pending·0 cites
- 0549US2023303676A1Anti-netrin-1 antibody to treat liver inflammationNETRIS PHARMA·Filed 2023·Application pending·0 cites
- 0646US2024342322A1Netrin-1 detection, companion test and therapy based on radiationsNETRIS PHARMA·Filed 2022·Application pending·0 cites
- 0745US12162932B2Combined treatment with Netrin-1 interfering drug and immune checkpoint inhibitors drugsNETRIS PHARMA·Filed 2018·Granted Dec 10, 2024·0 cites·10 claims
- 0833US9895439B2Combined treatment with netrin-1 interfering drug and chemotherapeutic drugNETRIS PHARMA·Filed 2013·Granted Feb 20, 2018·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →